Welcome to TGR BioSciences

Producing high-value therapeutic products in gastro-intestinal health, skin and tissue repair

Healthcare
TGR BioSciences Pty Ltd (TGR) is a private biotechnology company based in Adelaide, South Australia. TGR's primary business focus is on the discovery and development of scientifically proven products that can be marketed as high-value therapies in oral and gastro-intestinal health, skin and tissue repair. A lead product is in clinical trials for the prevention of oral mucositis, the debilitating mouth ulcers that affect over 40% of all chemotherapy patients and 60% of head-neck radiotherapy patients.

TGR has a number of products in development targeted towards wound repair, tissue engineering, skin regeneration, and dermatology.

High-throughput Screening & Cell-based Assay Technologies
TGR has developed leading-edge, cell-based screening technology for high-throughput discovery of novel bioactives. In addition to the application of this proprietary technology to our own discovery program, TGR generates revenue through the sale of SureFire^® high throughput assay kits to biotechnology and pharmaceutical companies through an alliance with Perkin-Elmer LAS, and by offering bioactive discovery collaborations worldwide.


SUREFIRE is a registered trademark of TGR BioSciences Pty Ltd, Australia.